Cargando…
Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria
BACKGROUND: Portal hypertension (PH) causes severe complications in patients with liver cirrhosis, such as variceal bleeding and ascites; however, data on the knowledge and perceptions on guideline recommendations for the management of varices and the use of albumin is scarce. METHODS: We designed t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116244/ https://www.ncbi.nlm.nih.gov/pubmed/33270161 http://dx.doi.org/10.1007/s00508-020-01769-9 |
_version_ | 1783691352673878016 |
---|---|
author | Pfisterer, Nikolaus Schmidbauer, Caroline Riedl, Florian Maieron, Andreas Stadlbauer, Vanessa Hennlich, Barbara Schwarzer, Remy Puespoek, Andreas Bucsics, Theresa Effenberger, Maria Bota, Simona Gschwantler, Michael Peck-Radosavljevic, Markus Mandorfer, Mattias Madl, Christian Trauner, Michael Reiberger, Thomas |
author_facet | Pfisterer, Nikolaus Schmidbauer, Caroline Riedl, Florian Maieron, Andreas Stadlbauer, Vanessa Hennlich, Barbara Schwarzer, Remy Puespoek, Andreas Bucsics, Theresa Effenberger, Maria Bota, Simona Gschwantler, Michael Peck-Radosavljevic, Markus Mandorfer, Mattias Madl, Christian Trauner, Michael Reiberger, Thomas |
author_sort | Pfisterer, Nikolaus |
collection | PubMed |
description | BACKGROUND: Portal hypertension (PH) causes severe complications in patients with liver cirrhosis, such as variceal bleeding and ascites; however, data on the knowledge and perceptions on guideline recommendations for the management of varices and the use of albumin is scarce. METHODS: We designed two structured surveys on (i) the management of varices and (ii) the use of albumin for Austrian physicians of specialized Gastro-Intestinal (GI) centers. The interviewed physicians were confronted spontaneously and provided ad hoc responses to the questionnaire. RESULTS: In total, 158 surveys were completed. Interestingly, many specialists (30%) would recommend a follow-up gastroscopy after 1 year in patients with compensated cirrhosis without varices (i.e., overtreatment). For small varices, 81.5% would use non-selective beta blockers (NSBB) for primary prophylaxis (PP). For PP in patients with large varices, endoscopic band ligation (EBL) plus NSBB was preferred by 51.4% (i.e., overtreatment). Knowledge on the indication criteria for early TIPS (transjugular intrahepatic portosystemic shunt) was reported by 54.3%, but only 20% could report these criteria correctly. The majority (87.1%) correctly indicated a preference to use NSBB and EBL for secondary prophylaxis (SP). The majority of participating gastroenterologists reported no restrictions on the use of albumin (89.8%) in their hospitals. Of the interviewed specialists, 63.6% would use albumin in patients with SBP; however, only 11.4% would use the doses recommended by guidelines. The majority of specialists indicated using albumin at the recommended doses for hepatorenal syndrome (HRS-AKI, 86.4%) and for large volume paracentesis (LVP, 73.3%). The individual responses regarding albumin use for infections/sepsis, hyponatremia, renal impairment, and encephalopathy were heterogeneous. CONCLUSION: The reported management of PH and varices is mostly adherent to guidelines, but endoscopic surveillance in patients without varices is too intense and EBL is overused in the setting of PP. Knowledge on the correct use of early TIPS must be improved among Austrian specialists. Albumin use is widely unrestricted in Austria; however, albumin is often underdosed in established indications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00508-020-01769-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8116244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-81162442021-05-13 Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria Pfisterer, Nikolaus Schmidbauer, Caroline Riedl, Florian Maieron, Andreas Stadlbauer, Vanessa Hennlich, Barbara Schwarzer, Remy Puespoek, Andreas Bucsics, Theresa Effenberger, Maria Bota, Simona Gschwantler, Michael Peck-Radosavljevic, Markus Mandorfer, Mattias Madl, Christian Trauner, Michael Reiberger, Thomas Wien Klin Wochenschr Original Article BACKGROUND: Portal hypertension (PH) causes severe complications in patients with liver cirrhosis, such as variceal bleeding and ascites; however, data on the knowledge and perceptions on guideline recommendations for the management of varices and the use of albumin is scarce. METHODS: We designed two structured surveys on (i) the management of varices and (ii) the use of albumin for Austrian physicians of specialized Gastro-Intestinal (GI) centers. The interviewed physicians were confronted spontaneously and provided ad hoc responses to the questionnaire. RESULTS: In total, 158 surveys were completed. Interestingly, many specialists (30%) would recommend a follow-up gastroscopy after 1 year in patients with compensated cirrhosis without varices (i.e., overtreatment). For small varices, 81.5% would use non-selective beta blockers (NSBB) for primary prophylaxis (PP). For PP in patients with large varices, endoscopic band ligation (EBL) plus NSBB was preferred by 51.4% (i.e., overtreatment). Knowledge on the indication criteria for early TIPS (transjugular intrahepatic portosystemic shunt) was reported by 54.3%, but only 20% could report these criteria correctly. The majority (87.1%) correctly indicated a preference to use NSBB and EBL for secondary prophylaxis (SP). The majority of participating gastroenterologists reported no restrictions on the use of albumin (89.8%) in their hospitals. Of the interviewed specialists, 63.6% would use albumin in patients with SBP; however, only 11.4% would use the doses recommended by guidelines. The majority of specialists indicated using albumin at the recommended doses for hepatorenal syndrome (HRS-AKI, 86.4%) and for large volume paracentesis (LVP, 73.3%). The individual responses regarding albumin use for infections/sepsis, hyponatremia, renal impairment, and encephalopathy were heterogeneous. CONCLUSION: The reported management of PH and varices is mostly adherent to guidelines, but endoscopic surveillance in patients without varices is too intense and EBL is overused in the setting of PP. Knowledge on the correct use of early TIPS must be improved among Austrian specialists. Albumin use is widely unrestricted in Austria; however, albumin is often underdosed in established indications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00508-020-01769-9) contains supplementary material, which is available to authorized users. Springer Vienna 2020-12-03 2021 /pmc/articles/PMC8116244/ /pubmed/33270161 http://dx.doi.org/10.1007/s00508-020-01769-9 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Pfisterer, Nikolaus Schmidbauer, Caroline Riedl, Florian Maieron, Andreas Stadlbauer, Vanessa Hennlich, Barbara Schwarzer, Remy Puespoek, Andreas Bucsics, Theresa Effenberger, Maria Bota, Simona Gschwantler, Michael Peck-Radosavljevic, Markus Mandorfer, Mattias Madl, Christian Trauner, Michael Reiberger, Thomas Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria |
title | Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria |
title_full | Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria |
title_fullStr | Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria |
title_full_unstemmed | Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria |
title_short | Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria |
title_sort | perceptions on the management of varices and on the use of albumin in patients with cirrhosis among gi specialists in austria |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116244/ https://www.ncbi.nlm.nih.gov/pubmed/33270161 http://dx.doi.org/10.1007/s00508-020-01769-9 |
work_keys_str_mv | AT pfisterernikolaus perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT schmidbauercaroline perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT riedlflorian perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT maieronandreas perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT stadlbauervanessa perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT hennlichbarbara perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT schwarzerremy perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT puespoekandreas perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT bucsicstheresa perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT effenbergermaria perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT botasimona perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT gschwantlermichael perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT peckradosavljevicmarkus perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT mandorfermattias perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT madlchristian perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT traunermichael perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria AT reibergerthomas perceptionsonthemanagementofvaricesandontheuseofalbumininpatientswithcirrhosisamonggispecialistsinaustria |